Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia

Table 2

Abnormal laboratory results for COVID-19 patients and CAP patients.

Variate	COVID-19 ()	CAP ()
CD3^+			<0.001
Normal	185 (62.5%)	56 (43.1%)
High	0 (0%)	2 (1.5%)
Low	111 (37.5%)	72 (55.4%)
CD19^+			0.032
Normal	81 (27.4%)	35 (26.9%)
High	0 (0%)	3 (2.3%)
Low	215 (72.6%)	92 (70.8%)
CD3^+CD4^+			<0.001
Normal	217 (73.3%)	59 (45.4%)
High	0 (0%)	1 (0.8%)
Low	79 (26.7%)	70 (53.8%)
CD3^+CD8^+			0.216
Normal	140 (47.3%)	55 (42.3%)
High	0 (0%)	1 (0.8%)
Low	156 (52.7%)	74 (56.9%)
CD16^+CD56^+			0.008
Normal	129 (43.6%)	39 (30%)
Low	167 (56.4%)	91 (70%)
4/8 ratio			<0.001
Normal	169 (57.1%)	58 (44.6%)
High	88 (29.7%)	26 (20%)
Low	39 (13.2%)	46 (35.4%)
CD3^+% lym			0.679
Normal	153 (51.7%)	70 (53.8%)
High	139 (47%)	57 (43.8%)
Low	4 (1.4%)	3 (2.3%)
CD19^+% lym			0.004
Normal	164 (55.4%)	66 (50.8%)
High	15 (5.1%)	19 (14.6%)
Low	117 (39.5%)	45 (34.6%)
CD3^+CD4^+% lym			<0.001
Normal	106 (35.8%)	69 (51.1%)
High	189 (63.9%)	45 (36.7%)
Low	1 (0.3%)	16 (12.2%)
CD3^+CD8^+% lym			<0.001
Normal	264 (89.2%)	88 (67.7%)
High	15 (5.1%)	34 (26.2%)
Low	17 (5.7%)	8 (6.2%)
CD16^+CD56^+% lym			0.018
Normal	231 (78%)	88 (67.7%)
High	16 (5.4%)	5 (3.8%)
Low	49 (16.6%)	37 (28.5%)